Showing 5,901 - 5,920 results of 102,295 for search '(( 5 ((nn decrease) OR (a decrease)) ) OR ( 50 ((mg decrease) OR (mean decrease)) ))', query time: 1.45s Refine Results
  1. 5901
  2. 5902
  3. 5903
  4. 5904
  5. 5905

    Pro-apoptotic markers are decreased after IGFBP-3 NB injections. by Youde Jiang (436930)

    Published 2014
    “…<p>For all studies, groups are control (ctrl), diabetic (Diabetic), Diabetic +IGFBP-3 NB (Diab +BP3), Diabetic +CMV (Diab+CMV), Diabetic+IGFBP-3 NB left eye (Diab+BP3 contra) and Diabetic+CMV left eye (Diab+CMV Contra). Panels A&B show that Bax (A) and cleaved caspase 3 (B) levels are all decreased after the IGFBP-3 NB intravitreal injections. …”
  6. 5906
  7. 5907
  8. 5908
  9. 5909
  10. 5910
  11. 5911
  12. 5912
  13. 5913
  14. 5914

    Brivanib decreases viability of PDGF-BB treated LX-2 cells. by Ikuo Nakamura (548298)

    Published 2014
    “…(B) Cells stimulated with 5 ng/ml PDGF-BB in serum-free medium showed a similar trend albeit more pronounced decrease in viability compared to cells cultured in 10% FBS. …”
  15. 5915

    Decreased liver metastasis of circulating CXCL12-expressing PDAC cells. by Ishan Roy (530438)

    Published 2014
    “…(C) <i>Ex vivo</i> radiance of excised spleen (C), reflecting tumor cells at the site of injection, or the metastatic destination (D), reflecting decreased hepatic metastasis of CXCL12-expressing cells relative to GFP-cells. (**) denotes <i>P</i>≤0.01, n = 4–5. …”
  16. 5916
  17. 5917
  18. 5918

    Autocrine CXCL12 decreases cell adhesion of colorectal carcinoma cells. by Luke J. Drury (241337)

    Published 2010
    “…GAPDH expression served as a loading control. (B) HT29 cells cultured in complete medium exhibit decreased adhesion after 6-days in culture (D0, D2, D4, D5, D6) compared to control (GFP) cells by phase microscopy (10X). …”
  19. 5919
  20. 5920

    Antisense RNA decreases AP33 gene expression and cytoadherence by -1 by V Mundodi (32881)

    Published 2011
    “…The blots were probed with mAb F5.2 to AP33 (panel 1), mAb 12G4 to AP65 (panel 2) [17], and mAb to α-tubulin (panel 3). …”